ethanolamine oleate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4086 2272-11-9

Description:

MoleculeDescription

Synonyms:

  • ethamolin
  • ethanolamine oleate
  • monoethanolamine oleate
used for treatment of pyogenic granuloma
  • Molecular weight: 343.55
  • Formula: C20H41NO3
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 37.30
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Dec. 22, 1988 FDA QOL MEDCL
June 26, 2017 PMDA Fuji Chemical Industries Co., Ltd.

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C05BB01 CARDIOVASCULAR SYSTEM
VASOPROTECTIVES
ANTIVARICOSE THERAPY
Sclerosing agents for local injection
MeSH PA D002317 Cardiovascular Agents
MeSH PA D019999 Pharmaceutical Solutions
MeSH PA D012597 Sclerosing Solutions

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D02276 KEGG_DRUG
4019473 VANDF
C0059699 UMLSCUI
CHEMBL3989529 ChEMBL_ID
DB06689 DRUGBANK_ID
CHEMBL104943 ChEMBL_ID
C033343 MESH_SUPPLEMENTAL_RECORD_UI
5282489 PUBCHEM_CID
C431086 MESH_SUPPLEMENTAL_RECORD_UI
4152 INN_ID
U4RY8MRX7C UNII
224898 RXNORM
2469 MMSL
4695 MMSL
d01382 MMSL
000707 NDDF
386974002 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Ethamolin HUMAN PRESCRIPTION DRUG LABEL 1 67871-479 INJECTION, SOLUTION 50 mg INTRAVENOUS NDA 17 sections
Ethamolin HUMAN PRESCRIPTION DRUG LABEL 1 67871-479 INJECTION, SOLUTION 50 mg INTRAVENOUS NDA 17 sections